Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [1]. Core Views - The company achieved a revenue of 14.3 billion HKD in 2025, representing a year-on-year growth of 21%, while the net profit attributable to shareholders was 1.06 billion HKD, down 19% year-on-year [1]. - The company’s dividend for 2025 is set at 0.2 HKD per share, reflecting confidence in future growth [1]. - The report highlights the recovery in the vaping business, driven by regulatory changes and market expansion in the U.S. and Europe, with a notable increase in revenue from self-owned brands [2]. - The HNB (Heated Not Burned) segment shows significant growth potential, with a revenue increase of 476% year-on-year, and plans for further market expansion in 2026 [3]. - The emerging medical and beauty aerosol business is in the exploratory phase, with high R&D investments impacting current performance but promising long-term profitability [3]. - The company is expected to maintain a strong dividend yield of 3.36% in 2025, indicating confidence in its long-term growth trajectory [4]. Summary by Relevant Sections Revenue and Profitability - In 2025, the company reported a revenue of 14.3 billion HKD, with a 22% increase in the second half to 8.2 billion HKD, while the net profit for the same period was 570 million HKD, down 8% [1]. - The adjusted net profit for 2025, excluding stock incentive expenses, was 1.53 billion HKD, reflecting a 1.3% increase year-on-year [1]. Business Segments - The vaping business generated revenues of 7.1 billion HKD in the U.S., 4.1 billion HKD in Europe, and 200 million HKD in China, with year-on-year growth rates of 19%, 2%, and -11% respectively [2]. - The HNB segment achieved a revenue of 1.3 billion HKD, with a year-on-year growth of 476%, and is set to expand into more core markets [3]. - The medical and beauty aerosol segment is preparing for FDA approval and aims to build small-scale production capabilities, with long-term revenue potential [3]. Financial Projections - Revenue projections for 2026-2028 are 16.91 billion HKD, 19.98 billion HKD, and 23.66 billion HKD, with year-on-year growth rates of 18.64%, 18.13%, and 18.42% respectively [4]. - The net profit projections for the same period are 1.65 billion HKD, 2.57 billion HKD, and 3.49 billion HKD, with growth rates of 55.20%, 55.58%, and 35.69% respectively [4]. - The expected EPS for 2025-2027 is 0.27 HKD, 0.41 HKD, and 0.56 HKD, with corresponding P/E ratios of 42, 27, and 20 times [4].

Group 1 - The company forecasts a revenue of 6.013 billion yuan for H1 2025, representing an 18% year-on-year increase, while net profit is expected to be between 443 million and 541 million yuan, reflecting a decline of 21% to 35% year-on-year [1] - The decline in profit is attributed to increased non-cash expenses related to stock options and awards, higher distribution and sales expenses due to market expansion, and a significant rise in legal service costs [1] - Adjusted net profit, excluding non-cash stock-based payment expenses, is projected to be between 688 million and 787 million yuan, indicating a year-on-year change of -9% to +4% [1] Group 2 - The company's vaping business benefits from the global market's compliance development, with revenue growth driven by proprietary brand and enterprise customer business [1] - In the UK, a ban on disposable e-cigarettes has caused significant market disruption, leading to a shift in demand towards reusable e-cigarette products [1] - In the US, the FDA and CBP have intensified actions against illegal e-cigarettes, seizing over 135 million USD worth of products since 2023, which is expected to support the growth of the company's proprietary brand and enterprise customer business [1] Group 3 - British American Tobacco's Glo Hilo product, utilizing infrared quartz heating technology, is set for nationwide launch in Japan after successful trials, with a retail price of approximately 25 USD [2] - The company aims to revitalize market growth in Japan, which is a key strategic market for smoke-free products, as sales of smoke-free products have surpassed traditional cigarettes [2] - The HNB business is expected to contribute significantly to revenue growth starting in 2025, with projected net profits for 2025-2027 being 1.337 billion, 1.912 billion, and 2.760 billion yuan respectively, reflecting year-on-year growth rates of +2.57%, +43.01%, and +44.35% [2]